Furosemide topical gel CLS006
Term · Oncology and biomedicine · MLC-T-ONC-013789
A sulfamoylanthranilic acid derivative and loop diuretic, with potential antiviral activity. Upon topical administration, furosemide gel inhibits potassium influx by interacting with cell membrane ion co-transporter, Na+-K+-2Cl-co-transporter-1(NKCC1; SLC12A2). This may inhibit potassium influx and prevent the replication of DNA viruses, such as human papillomavirus (HPV), that rely on potassium for replication.
| Identifier | MLC-T-ONC-013789 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | furosemide topical gel CLS 006; furosemide topical gel CLS-006 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013789",
"term": "Furosemide topical gel CLS006",
"field": "Oncology and biomedicine",
"definition": "A sulfamoylanthranilic acid derivative and loop diuretic, with potential antiviral activity. Upon topical administration, furosemide gel inhibits potassium influx by interacting with cell membrane ion co-transporter, Na+-K+-2Cl-co-transporter-1(NKCC1; SLC12A2). This may inhibit potassium influx and prevent the replication of DNA viruses, such as human papillomavirus (HPV), that rely on potassium for replication.",
"synonyms": [
"furosemide topical gel CLS 006",
"furosemide topical gel CLS-006"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/furosemide-topical-gel-cls006/"
}
Record 7,649 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.